| Financial Year |
March 31 2023 |
| Monetary Funds |
196,607,707.87 |
| Held-for-trading Financial Assets |
31,239,125.89 |
| Notes Receivable |
798,342.78 |
| Accounts Receivable |
14,886,650.51 |
| Advances to Suppliers |
26,340,301.41 |
| Other Receivables |
171,511,637.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,500,000.00 |
| Inventories |
521,351,707.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
140,937,938.03 |
| Total Current Assets |
1,103,673,411.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,604,832.56 |
| Long-term Equity Investment |
362,392,452.50 |
| Investment Properties |
81,185,886.13 |
| Fixed Assetes |
1,593,192,639.43 |
| Under-construction Projects |
15,536,529.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
206,382,663.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
254,539,256.11 |
| Deferred Income Tax Assets |
8,709,614.68 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,044,352,966.93 |
| Total Assets |
4,148,026,378.72 |
| Short-Term Loans |
342,710,343.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
582,462,814.03 |
| Accounts Received In Advance |
20,591,714.22 |
| Employee Compensation Payable |
4,477,246.63 |
| Taxes Payable |
8,764,379.79 |
| Interest Payable |
-- |
| Dividend Payable |
3,155,632.64 |
| Other payables |
276,647,438.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
366,024,034.42 |
| Other Current Liabilities |
149,060,011.19 |
| Sub-Total of Current Liabilities |
2,948,360,980.93 |
| Long-term Loans |
230,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
92,015,309.63 |
| Deferred Income Tax Liabilities |
9,295,754.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
802,292,180.24 |
| Total Liabilities |
3,750,653,161.17 |
| Paid-In Capital(Or Share Stock) |
311,491,352.00 |
| Capital Surplus |
403,715,228.98 |
| Surplus Reserve |
108,777,062.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-481,362,657.03 |
| Minority Stockholder's Interest |
16,499,513.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
380,873,704.35 |
| Owner's Equity（Stockholder's Equity） |
397,373,217.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,148,026,378.72 |
